Professor of Clinical Endocrinology, King’s College London & Honorary Consultant, Guy’s and St Thomas’ NHS Foundation Trust

Prof Emma Duncan is Professor of Clinical Endocrinology at King’s College London, and Honorary Consultant, Department of Endocrinology, Guy’s and St Thomas’ NHS Foundation Trust. After training in medicine at University of Sydney, she undertook her doctorate in the genetics of osteoporosis at the Wellcome Trust Centre, University of Oxford, in collaboration with the Open University. Returning to Australia in 2005, Emma held professorial appointments at University of Queensland and Queensland University of Technology and practised as pre-eminent senior staff specialist at Princess Alexandra Hospital and Royal Brisbane and Women’s Hospital. In 2020 she moved back to the UK.

Since her undergraduate days Emma has been fascinated by endocrinology in general and bone in particular. Her basic research spans the genetics of many skeletal disorders, from common variant to rare monogenic diseases, and she has pioneered the translation of genetic technologies into clinical practice. Emma has also led multiple other projects in diabetes and endocrinology; and she is a clinical thought-leader in metabolic bone diseases and skeletal dysplasias internationally. She was recently awarded the European Calcified Tissues Society Kyowa Kirin Maria Luisa Bianchi Clinical Research Award for Rare Bone Diseases. During the pandemic she established and led multiple studies in COVID-19, including studies of SARS-CoV-2 in children and the genetics of the post-COVID syndrome; and she co-created the COVID Symptom Study Biobank. As the pandemic subsides, she is enjoying returning to genomics, bone, and general endocrinology research.

Emma contributes to leadership and governance nationally and internationally. She is the current President of the American Society for Bone and Mineral Research, in which role she is championing basic and clinical research in bone and musculoskeletal diseases, and cooperation in musculoskeletal health globally.